IP Library › Granted Patent US 7,582,612
Granted Patent B2
US 7,582,612 · App. 10/910,504 · Granted Sep 1, 2009

Multi-action anthelmintic formulations

Assignees: Hartz Mountain Corporation; Virbac Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,582,612
App. No.
10/910,504
Granted
Sep 1, 2009
Kind
B2
Abstract

The present invention provides a method for preparing a pharmaceutical formulation containing ivermectin and a method and composition that can contain ivermectin plus tetrahydropyrimidines. An examples of a tetrahydropyrimidine includes pyrantel. A pharmaceutical formulation is provided for use in the treatment of helminthiasis of mammals, and particularly tapeworm, hookworm, roundworm and heartworm of domestic animals and farm animals. The present invention also provides a method of treating helminthiasis in mammals, which method comprises administering to the mammal in need thereof an anthelmintically effective amount of a pharmaceutical formulation of the invention.

Claims (33)

1. A method for forming an anthelmintic formulation comprising the steps of:

preparing a combination of ivermectin, an alcohol, and a second material, wherein the second material comprises polyethylene glycol; then

spray granulating the combination to form granules, with the polyethylene glycol covering the ivermectin, and

combining the granules with an additional active ingredient composition.

2. The method of claim 1 , wherein the additional ingredient composition consists essentially of a pyrantel or pyrantel pamoate.

3. The method of claim 1 , comprising adding an anthelmintic pyrimidine to the formulation.

4. The method of claim 1 , wherein the formulation is pressed into a tablet or enclosed in a capsule and the ivermectin has been effectively isolated, so that the formulation will stay stable for over one month.

5. The method of claim 1 , wherein the spray granulating step maintains the ivermectin stable for over one month.

6. A method for forming an anthelmintic formulation, comprising the steps of:

a) preparing a first preparation comprising an avermectin, polyethylene glycol, and water;

b) preparing a second preparation comprising a tetrahydropyrimidine and water, wherein the avermectin and tetrahydropyrimidine preparations together comprise an anthelmintic combination

c) separately forming solids from the first and second preparations, said solid forming step comprising spray granulating the first preparation with the polyethylene glycol covering the avermectin; and

d) combining the solid preparations to form an anthelmintic solid, consisting essentially of the avermectin and the tetrahydropyrimidine, with one or more appropriate excipients to provide the combinations in a form suitable to be administered to a mammal.

7. The method of claim 6 , wherein the anthelmintic combination comprises ivermectin.

8. The method of claim 6 , wherein the anthelmintic combination comprises at least about 0.005% ivermectin.

9. The method of claim 6 , wherein the anthelmintic combination comprises about 0.012-5% ivermectin.

10. The method of claim 6 , wherein the anthelmintic combination comprises pyrantel pamoate.

11. The method of claim 6 , wherein the anthelmintic combination comprises at least about 1.5% pyrantel pamoate.

12. The method of claim 6 , wherein the anthelmintic combination comprises about 11.2-23% pyrantel pamoate.

13. The method of claim 6 , wherein the solid forming step comprises spray granulating ivermectin.

14. A method for forming an anthelmintic formulation comprising the steps of:

a) preparing a first preparation comprising an avermectin, polyethylene glycol and an alcohol;

b) preparing a second preparation comprising a tetrahydropyrimidine and an alcohol, wherein the avermectin and tetrahydropyrimidine preparations together comprise an anthelmintic combination

c) separately forming solids from the first and second preparations, said solid forming step comprising spray granulating the first preparation with the polyethylene glycol covering the avermectin; and

d) combining the solid preparations to form an anthelmintic solid, consisting essentially of the avermectin and the tetrahydropyrimidine, with one or more appropriate excipients to provide the combinations in a form suitable to be administered to a mammal.

15. The method of claim 14 , wherein the anthelmintic combination comprises ivermectin.

16. The method of claim 14 , wherein the anthelmintic combination comprises at least about 0.005% ivermectin.

17. The method of claim 14 , wherein the anthelmintic combination comprises about 0.012-5% ivermectin.

18. The method of claim 14 , wherein the anthelmintic combination comprises pyrantel pamoate.

19. The method of claim 14 , wherein the anthelmintic combination comprises at least about 1.5% pyrantel pamoate.

20. The method of claim 14 , wherein the anthelmintic combination comprises about 11.2-23% pyrantel pamoate.

21. The method of claim 14 , wherein the alcohol is selected from the group consisting of ethanol, butanol, benzyl alcohol, and isopropanol.

22. The method of claim 14 , wherein the solid forming step comprises spray granulating ivermectin.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2014
From: THE HARTZ MOUNTAIN CORPORATION
To: VIRBAC CORPORATION
Reel/Frame 033916/0585 →
ASSIGNMENT OF 50% UNDIVIDED INTEREST Recorded Aug 11, 2006
From: HARTZ MOUNTAIN CORPORATION, THE
To: VIRBAC CORPORATION
Reel/Frame 018105/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2006
From: CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED
To: HARTZ MOUNTAIN CORPORATION
Reel/Frame 018083/0265 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2005
From: AHN, ALBERT; COTTRELL, IAN
To: HARTZ MOUNTAIN CORPORATION, THE; CHANELLE PHARMACEUTICALS MANUFACTURING LTD.
Reel/Frame 015994/0376 →
Continuity (2)
Provisional Application 6055268200 · Mar 12, 2004
Related Publication 20050203034A1 · Sep 15, 2005